SCHEMBL24835233

SCHEMBL24835233

CCN(CCc1ccc(C(=O)OC)cc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
CYP4A11 Q02928 2/20 0.50
MGLL Q99685 1/20 0.49
CYP4F2 P78329 1/20 0.49
TSHR P16473 1/20 0.49
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
ESRRG P62508 2/20 0.46
LOXL2 Q9Y4K0 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24835159 0.85 NR1H2 (0.51) MEN1KMT2ATSHRMAPTALDH1A1
Hydrochloric Acid SCHEMBL27900963 0.84 TSHR (0.58) MEN1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL11677518 0.83 SMN1; SMN2 (0.52) MEN1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL11676189 0.81 MAPT (0.65) MEN1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL24835163 0.80 KDM4E (0.61) CYP4A11MGLLMAPTKDM4EALDH1A1
SCHEMBL24835214 0.79 CYP4A11 (0.58) MEN1KMT2ACYP4A11CYP4F2TSHR
SCHEMBL65794 0.78 MAPT (0.61) MEN1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL1928912 0.78 TSHR (0.67) CYP4A11MGLLCYP4F2TSHRMAPT
SCHEMBL10524794 0.78 TSHR (0.64) TSHRNR1H2NR1H3
SCHEMBL6256717 0.78 ESRRG (0.50) MEN1KMT2AMGLLTSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278698-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2023-01-05 WO disclosed